StockData
Waters Corp logo

Waters Corp (WAT) stock analysis

WATNYSELaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30772% above fair value
$470.90−4.62 (-0.97%)

Close on Nov 11, 2026Market cap $46.27BP/E 202.1Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth2Performance1Health4Dividend0

Weak8 of 30 checks passed

Waters passes 8 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
2/6
Past performance
1/6
Financial health
4/6
Dividend
0/6

What stands out

  • Low debt

    Debt is 29.3% of shareholders' equity, under the 40% we consider low.

  • Low bankruptcy risk

    The Altman Z-score is 4.11; above 3 is the safe zone and below 1.8 the distress zone.

  • Guidance raised

    Waters raised its third quarter 2026 Total Company reported revenue outlook on Aug 4, 2026.

  • P/B below the industry

    Waters's price-to-book of 3.03 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

What to watch

  • Margin of safety under 20%

    The price is 772% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $470.90 is above our fair value estimate of $54.03.

  • Return on equity under 15%

    Return on equity was 1.1% over the last twelve months and averaged 78.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 2.2%, below the 10% that usually covers the cost of capital.

Valuation1/6
  • P/E above its 5-year median

    Waters's P/E of 202.1 is above its own 5-year median of 29.8.

  • P/E above the industry

    Waters's P/E of 202.1 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.

  • EV/EBITDA above its 5-year median

    Waters's EV/EBITDA of 188.9 is above its 5-year median of 25.0.

  • P/B below the industry

    Waters's price-to-book of 3.03 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

  • Trading above fair value

    The share price of $470.90 is above our fair value estimate of $54.03.

  • Margin of safety under 20%

    The price is 772% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 2.1% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -2.8% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 80.7% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Guidance raised

    Waters raised its third quarter 2026 Total Company reported revenue outlook on Aug 4, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance1/6
  • Return on equity under 15%

    Return on equity was 1.1% over the last twelve months and averaged 78.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 2.2%, below the 10% that usually covers the cost of capital.

  • Return on equity below the industry

    Waters's return on equity of 1.1% is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was 1.8% over the last twelve months, against a 5-year average of 21.9%.

  • Net margin above the industry

    Waters's net margin of 1.8% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.

Financial health4/6
  • Low debt

    Debt is 29.3% of shareholders' equity, under the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 584% five years ago to 29.3%.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals 10.7% of total debt; we look for at least 20%.

  • Interest not well covered

    Operating income covers interest expense 1.5 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 1.89 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 4.11; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    Waters has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$54.03

The share price is 772% above this estimate.

20%+ below
Near fair value
20%+ above
$470.90Price$54.03Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E33.1×29.8×36.5×$77.1544%
EV/EBITDA24.4×25.0×23.7×$26.3139%
P/Bleft out, too far from the others9.1×14.9×3.2×$1,412.61–
Earnings power9.5% cost of equity––$57.0417%
Fair value$54.03100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 29.8
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$447.12M
Value traded per 1% price move
$254.41M

Downside

Medium risk

Typical loss in a bad month
18.1%
Volatility (annualized)
35%
Sharpe ratio, 1 year
0.58
Beta to the S&P 500 (5Y)
0.93

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

59.3%+1.8 pts over 5 years

Operating margin

25.4%−1.9 pts over 5 years

Net margin

20.3%

See a number that looks wrong?